-
Jan 2007
Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.
Diabetes CareSosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. -
Nov 2006
Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives.
DiabetesStandifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Greenbaum CJ, Pihoker C, Nepom GT -
Sep 2006
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.
DiabetesSeyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC -
May 2006
Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.
J Clin Endocrinol MetabRedondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum CJ, Palmer JP, Cuthbertson DD, Eisenbarth GS, Krischer JP, Schatz DA, Diabetes Prevention Trial Type 1 Study Group. -
Apr 2006
Progress, but not yet ready for clinical use: interrupting immune-mediated destruction of pancreatic beta cells in type 1 diabetes.
Curr Diab RepGreenbaum CJ -
Mar 2006
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Diabetes CareSosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS -
Mar 2006
Evaluation of leptin levels in subjects at risk for type 1 diabetes.
J AutoimmunGilliam LK, Jensen RA, Yang P, Weigle DS, Greenbaum CJ, Pihoker C -
Mar 2006
Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects.
J ImmunolYang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum CJ, Pihoker C, James EA, Kwok WW -
Jan 2006
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.
Scand J ImmunolAlleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA -
Dec 2005
Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
J AutoimmunDanke NA, Yang J, Greenbaum CJ, Kwok WW -
Nov 2005
Latent autoimmune diabetes in adults (LADA) should be less latent.
DiabetologiaFourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC -
Nov 2005
Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes.
J AutoimmunGilliam LK, Brooks-Worrell BM, Palmer JP, Greenbaum CJ, Pihoker C -
May 2005
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
Diabetes CareSkyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum CJ, Cuthbertson DD, Rafkin-Mervis LE, Chase HP, Leschek E -
Jan 2005
High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes.
DiabetologiaGreenbaum CJ, Eisenbarth G, Atkinson M, Yu L, Babu S, Schatz D, Zeidler A, Orban T, Wasserfall C, Cuthbertson D, Krischer J, DPT-1 study group. -
Oct 2004
Non-invasive imaging of beta cell mass: a quantitative analysis.
Diabetes Technol TherSweet IR, Cook DL, Lernmark A, Greenbaum CJ, Krohn KA
